Related Business Topics
Latest Headlines
Reuters - Nov. 16, 2009, 7:44 AM
London Stock Exchange Announcement The Biotech Growth Trust PLC Unaudited Interim Report For the Six Months Ended 30 September 2009 INVESTMENT OBJECTIVE The Company seeks capital appreciation through investment in the worldwide biotechnology industry, ...
Forbes.com - Nov. 2, 2009, 3:13 AM
DUBLIN, Ireland Mr Stout has extensive pharmaceutical experience. Most recently he was President, Pharmaceutical Operations at GSK. In this position he had responsibility for pharmaceutical operations in the United States Mr Stout holds directorships at ...
CNBC - Nov. 2, 2009, 2:52 AM
/PRNewswire-FirstCall via COMTEX/ -- The Board of Directors of Shire plc (LSE: SHP, NASDAQ: SHPGY) announces that Mr David Stout joined the Board as a Non Executive Director with effect from 31 October 2009. Mr Stout has extensive pharmaceutical ...
CNBC - Oct. 19, 2009, 6:42 PM
OFFICIAL MAD MONEY WIDGET Grab this all-in-one application and get recaps of the show sent right to your desktop or blog. CRAMER'S SOUNDBOARD Admit it: You’ve always wanted to hit the “They know nothing!� button. Here’s your chance. CRAMER QUICK ...
CNBC - Oct. 13, 2009, 2:23 PM
WESTMINSTER, Colo. - Biopharmaceutical company Allos Therapeutics Inc. said Tuesday it completed a public offering of 14 million shares of common stock, generating net proceeds of about $93 million. The company had originally offered 11 million shares, ...
A-Z Allos Therapeutics, Inc. Provider Directory
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A

